Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04714216 · ClinicalTrials.gov registry record · NA
Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility
A NA study of Diabetes Mellitus, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 3
- Study locations
NCT04714216: Completed NA study of Diabetes Mellitus, sponsored by Emory University.
NCT04714216 is a NA study of Diabetes Mellitus that has completed, run by Emory University. The registered enrollment target is 22 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04714216, a NA study of Diabetes Mellitus, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 3
- Study locations
Study Summary
This single-arm stepwise feasibility study will test initial deployment of hybrid closed-loop (HCL) automated insulin delivery (AID) using the Omnipod 5/Horizon HCL system with remote monitoring and device operation capabilities to hospitalized patients admitted to the general medical/surgical floor with diabetes (type 1 or type 2) requiring insulin therapy.
Primary Outcome
The percentage of time spent in HCL after CGM sensor met initial validation criteria of sensor glucose value being within ±20% of point of care (POC) values (for glucose levels ≥70 mg/dL) or ±20 mg/dL for POC glucose values \<70 mg/dL.
Conditions Studied
Interventions
- DEVICE The Omnipod 5/Horizon HCL system
Study Locations (3)
California
- Stanford University School of Medicine - Stanford
Georgia
- Grady Health System (non-CRN) - Atlanta
Virginia
- University of Virginia School of Medicine - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2022-08-11 |
| Phase | NA |
What the finished NCT04714216 record still lists
NCT04714216 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which The Omnipod 5/Horizon HCL system is the first listed.
NCT04714216 reports a single indexed study location in California, Georgia, Virginia.
Frequently Asked Questions
What is clinical trial NCT04714216 about?
NCT04714216 is a clinical study titled "Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility". This single-arm stepwise feasibility study will test initial deployment of hybrid closed-loop (HCL) automated insulin delivery (AID) using the Omnipod 5/Horizon HCL system with remote monitoring and device operation capabilities to hospitalized patients admitted to the general medical/surgical floor...
What is the current status of trial NCT04714216?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2021-06-29. Estimated completion is 2022-08-11.
What conditions does trial NCT04714216 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
What interventions are being tested in trial NCT04714216?
The interventions under investigation include: The Omnipod 5/Horizon HCL system (DEVICE).
Who is sponsoring clinical trial NCT04714216?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04714216 being conducted?
This trial has 3 study locations across California, Georgia, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04714216's enrollment target sits among peer trials
22 192nd of 208 higher than 16 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI